Status: Recruiting
A Clinical Study to Evaluate the Safety and Tolerability of AWT020 in Patients With Advanced Malignancies
The purpose of this phase I clinical study was to evaluate the safety and tolerability of AWT020 monotherapy and combination with other antitumor therapies in patients with advanced malignancies
Participants needed: 214
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Shanghai Junshi Bioscience Co., Ltd.Updated: Jul 2, 2026Locations: 13
Eligibility criteria
Both male and female subjects who are at least 18 years old at the time of signi... [+18]
received chemotherapy, immunotherapy and other anti-tumor therapy or other inves... [+19]